Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Trajan Group HoldingsFRA:Z0M 23 Interest Coverage is 0.67 as of Dec. 2025, which is 65% below its 10-year median of 1.92. GuruFocus rates FRA:Z0M with a GF Score™ of 23/100 and a GF Value™ of €0.62 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 466 Medical Devices & Instruments companies, Trajan Group Holdings ranks worse than 93.99% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Trajan Group Holdings's
Operating Income
for the
six
months ended in Dec. 2025 was €0.60 Mil. Trajan Group Holdings's Interest Expense for the
six
months ended in Dec. 2025 was €-0.89 Mil.
Trajan Group Holdings's interest coverage for the quarter that ended in Dec. 2025 was 0.67.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Trajan Group Holdings's Interest Coverage or its related term are showing as below:
FRA:Z0M'
s Interest Coverage Range Over the Past 10 Years
Min: 0.07 Med: 1.92 Max: 8.48
Current: 1.1
FRA:Z0M's Interest Coverage is ranked worse than 93.99% of 466
companies
in the Medical Devices & Instruments industry
Industry Median: 16.05
vs FRA:Z0M: 1.10
Trajan Group Holdings (FRA:Z0M) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Trajan Group Holdings Interest Coverage Related Terms
Trajan Group Holdings Interest Coverage Historical Data
* Premium members only.
The historical data trend for Trajan Group Holdings's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
FRA:Z0M vs ISRG, BDX, MDLN: Interest Coverage Comparison
For the Medical Instruments & Supplies subindustry, Trajan Group Holdings's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trajan Group Holdings Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Trajan Group Holdings's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Trajan Group Holdings's Interest Coverage falls into.
Trajan Group Holdings Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trajan Group Holdings (FRA:Z0M) has a Interest Coverage of 0.67 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Trajan Group Holdings and its competitors. This is 65% below median its historical median of 1.92. Over the past decade, Trajan Group Holdings' Interest Coverage has ranged from 0.07 to 8.48. According to the industry distribution chart, Trajan Group Holdings ranks #438 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 94%.
Is Trajan Group Holdings' Interest Coverage too high?
Trajan Group Holdings' current Interest Coverage of 0.67 is 65% below median its 10-year median of 1.92. Over the past 10 years, this metric has ranged from a low of 0.07 to a high of 8.48. The Medical Devices & Instruments industry median Interest Coverage is 16.05. Trajan Group Holdings' value of 0.67 is 95.8% below this industry median. Based on the distribution chart, Trajan Group Holdings ranks #438 out of 466 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Trajan Group Holdings has a GF Score™ of 23/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Trajan Group Holdings' Interest Coverage compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Trajan Group Holdings ranks #438 out of 466 companies for Interest Coverage. This places Trajan Group Holdings in the lower half of its industry. The industry median Interest Coverage is 16.05. Trajan Group Holdings' value of 0.67 is 95.8% below this benchmark. Historically, Trajan Group Holdings' own Interest Coverage has ranged from 0.07 to 8.48 over the past decade. While the company's 10-year median is 1.92 vs. the industry median of 16.05, Trajan Group Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 16.05, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Trajan Group Holdings's current Interest Coverage of 0.67 is 95.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Trajan Group Holdings and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 16.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trajan Group Holdings's current Interest Coverage is 0.67, which is 65% below median its own 10-year median of 1.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trajan Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, Trajan Group Holdings (FRA:Z0M) is currently considered Possible Value Trap. The stock's GF Value™ is €0.62, compared to a current price of €0.17 — trading 73.1% below its estimated fair value. The current Interest Coverage is 0.67, which is 65% below median its 10-year median of 1.92 and 95.8% below the Medical Devices & Instruments industry median of 16.05. Trajan Group Holdings' overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Trajan Group Holdings (FRA:Z0M), the current Interest Coverage is 0.67 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Trajan Group Holdings (FRA:Z0M) Overvalued in 2026?
Based on GuruFocus' analysis, Trajan Group Holdings stock appears to be undervalued.
The current stock price of €0.17 is trading 73.1% below its estimated GF Value™ of €0.62.
GuruFocus considers Trajan Group Holdings to be Possible Value Trap.
Key valuation signals for FRA:Z0M:
Interest Coverage: 0.67 (65% below median its 10-year median of 1.92)
GF Value™: €0.62 vs. price of €0.17 (73.1% below fair value)
Industry Position: 95.8% below the Medical Devices & Instruments median (#438 of 466)
No single metric tells the full story. See the FRA:Z0M stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Trajan Group Holdings Ltd is a developer and manufacturer of analytical and life sciences products and devices, seeking to enrich human well-being through scientific measurement. Its current portfolio of products comprises products, devices and solutions that are used in the analysis of biological, food, and environmental samples. The Group now reports in three operating segments: Components and Consumables, Capital Equipment and Disruptive Technologies. Key revenue is generated from Components and consumables, which include parts, supplies, components, and consumable products worldwide. The Group operates in Asia (Malaysia, Japan and Australia and New Zealand (ANZ)), USA and Europe, Middle East, Africa, and India (EMEA).
23GF Score
Get the complete analysis for FRA:Z0M
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:Z0M has been successfully added to your 
